MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.
Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Matteo, Pavia, Italy.
Marzia
M
Varettoni
Silvia
S
Zibellini
Luca
L
Arcaini
Emanuela
E
Boveri
Sara
S
Rattotti
Cristiana
C
Pascutto
Silvia
S
Mangiacavalli
Manuel
M
Gotti
Lara
L
Pochintesta
Marco
M
Paulli
Mario
M
Cazzola
D018450:Disease Progression; D006801:Humans; D007075:Immunoglobulin M; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000235:genetics* / Q000473:pathology; D009154:Mutation; D053594:Myeloid Differentiation Factor 88 / Q000235:genetics*; D011379:Prognosis; D016016:Proportional Hazards Models; D012307:Risk Factors
D007075:Immunoglobulin M; C507779:MYD88 protein, human; D053594:Myeloid Differentiation Factor 88